secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCorRx Inc. (BICX)
CIK:        0001443863
Form:       8-K
Filed at:   2022-01-19T23:59:59+00:00
Accession:  0001477932-22-000348
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCorRx raises $1M via private placement of 229,886 shares at $4.35/share to two directors
--------------------------------------------------------------------------------

- Gross proceeds of $1M from sale of 229,886 shares at $4.35 per share to Lucido and Galligan trusts.
- Both investors are BioCorRx board members; Louis Lucido and Joseph Galligan are the trustees.
- Use of proceeds: 48% for legal fees from Buchalter; 52% for general working capital and administration.
- Agreements became effective on January 12 (Lucido) and January 19 (Galligan) upon cash payment.
- Shares are restricted securities issued under Rule 506 of Regulation D and bear appropriate legends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1443863/000147793222000348/0001477932-22-000348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1443863/000147793222000348/bicx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-000348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer